Revenue
attach_money25M USD
YoY -87.9%
TRDAEntrada Therapeutics, Inc.$ --
Entrada Therapeutics, Inc.
TRDA
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-156M USD
YoY -431.8%
Net Income
verified-144M USD
YoY -319.0%
EPS
pie_chart-3.47USD
YoY -297.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress100%On Track
Revenue Progress25.4M
Revenue Forecast30.5M
Net Income Progress-143.8M
Net Income Forecast-143.8M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.